Latest data from October 8, 2021
Number of Health Center respondents = 18 (64% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 9,762 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 6.08% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 1,411 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 8.71% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 86.95% | 87.60% |
| White, Hispanic/Latino Patients | 1.09% | 1.98% |
| Black/African American, Non-Hispanic/Latino Patients | 3.01% | 3.12% |
| Black/African American, Hispanic/Latino Patients | 0.14% | 1.49% |
| Asian Patients3 | 0.12% | 0.14% |
| American Indian/Alaska Native Patients3 | 0.10% | 0.21% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.07% | 0.00% |
| Patients with More than one race3 | 0.83% | 0.57% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.26% | 0.85% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.02% | 1.49% |
| Unreported/Refused to Report Race and Ethnicity | 4.40% | 2.55% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 828 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 14.69% |
| COVID-19 Immunization Series Completed | 687 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 8.96% |
| COVID-19 Immunization Series Additional | 1,753 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 5.51% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 79.23% | 84.28% | 89.96% |
| White, Hispanic/Latino Patients | 0.36% | 1.31% | 0.00% |
| Black/African American, Non-Hispanic/Latino Patients | 12.56% | 4.95% | 4.68% |
| Black/African American, Hispanic/Latino Patients | 0.00% | 0.15% | 0.00% |
| Asian Patients3 | 0.12% | 0.00% | 0.00% |
| American Indian/Alaska Native Patients3 | 0.00% | 0.15% | 0.34% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% | 0.00% | 0.00% |
| Patients with More than one race3 | 0.48% | 1.16% | 0.23% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.12% | 0.58% | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.24% | 1.02% | 4.11% |
| Unreported/Refused to Report Race and Ethnicity | 6.88% | 6.40% | 0.68% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 16.67% |
| 1 to 24 Hours | 22.22% |
| More Than 24 Hours | 55.56% |
| N/A | 5.56% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 5.56% |
| Staffing to administer the vaccine | 44.44% |
| Vaccine confidence | 27.78% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 5.56% |
| None | 22.22% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 33.33% |
| Average Percent of Health Center Visits Conducted Virtually | 18.33% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 33.33% |
| Number of Mobile Van Sites | 3 |
| Number of Pop-up Clinics | 3 |
| Number of School-Based Vaccination Sites | 13 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 11.11% |
| Refer patients to another organization that provides monoclonal antibody therapies | 44.44% |
| None | 44.44% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 5.56% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 16.67% |
| Therapy administration/onsite logistics | 16.67% |
| Other | 5.56% |
| None | 55.56% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
